Loading provider…
Loading provider…
Radiation Oncology Physician in Rochester, MN
NPI: 1649562984Primary Practice Location
MAYO CLINIC HOSPITAL ROCHESTER
201 W Center St, Rochester, MN
Primary Employer
Mayo Clinic - Mayo Building and Gonda Building
mayoclinic.org
HQ Phone
Get MD Bradley's Phone Numberphone_androidMobile
Get MD Bradley's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
WI State Medical License
MN State Medical License
MN State Medical License
2012 - 2025
WI State Medical License
2014 - 2025

American Board of Radiology
Radiation Oncology
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Residency • Radiation Oncology
2012 - 2016
University Of Minnesota Medical School
med.umn.edu
Medical School
Until 2011
Gundersen Lutheran Medical Foundation
Internship • Transitional Year
2011 - 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77263Complex radiation therapy planning | 113 | 126 |
| 2 | 77334Design and construction of complex radiation treatment device | 101 | 175 |
| 3 | 77300Calculation of radiation therapy dose | 94 | 419 |
| 4 | 77301High precision radiation therapy planning | 93 | 108 |
| 5 | 77338Design and construction of radiation treatment device for high precision radiation therapy | 93 | 108 |
Authors: Allison Rosenthal, William Rule, Jonas Paludo, Arushi Khurana, Han Tun, Patrick Johnston, Ernesto Ayala, Omran Saifi, Madiha Iqbal, Hemant Murthy, Mohamed Kharfan Dabaja, Stephen Ansell
Journal: Radiother Oncol
Publication Date: 2021-12-07
Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer.
Authors: David Routman, Thomas Pisansky
Publication Date: 2020-05-28
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, OTHER: Laboratory Biomarker Analysis, RADIATION: External Beam Radiation Therapy, DRUG: Degarelix, DRUG: Bicalutamide, DRUG: Flutamide, DRUG: Goserelin Acetate, DRUG: Leuprolide Acetate, DRUG: Leuprolide, DRUG: Goserelin, DRUG: Nilutamide
Lead Sponsor: Mayo Clinic
Intervention / Treatment: PROCEDURE: Biospecimen Collection
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Placebo Administration, DRUG: Oxybutynin Chloride